Compare LASE & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LASE | BDSX |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.7M | 62.5M |
| IPO Year | 2022 | 2020 |
| Metric | LASE | BDSX |
|---|---|---|
| Price | $2.73 | $7.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | ★ 268.4K | 63.1K |
| Earning Date | 04-02-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,938,027.00 | ★ $80,173,000.00 |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | N/A | $25.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 89.34 | 22.29 |
| 52 Week Low | $1.71 | $3.44 |
| 52 Week High | $7.31 | $32.20 |
| Indicator | LASE | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 39.98 | 49.14 |
| Support Level | $2.70 | $7.77 |
| Resistance Level | $3.06 | $8.38 |
| Average True Range (ATR) | 0.22 | 0.55 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 4.92 | 24.49 |
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.